NCT06921824View on ClinicalTrials.gov

Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Glucose MetabolismGlucagon
Interventions
OTHER

Glucagon

A three-hour intravenous infusion with glucagon with increasing infusion rate (from 0,01 ng/kg/min up to 50 ng/kg/min)

All Listed Sponsors
lead

Nicolai Jacob Wewer Albrechtsen

OTHER

NCT06921824 - Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants | Biotech Hunter | Biotech Hunter